BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20007782)

  • 21. Electrophysiological characterization of Ts6 and Ts7, K⁺ channel toxins isolated through an improved Tityus serrulatus venom purification procedure.
    Cerni FA; Pucca MB; Peigneur S; Cremonez CM; Bordon KC; Tytgat J; Arantes EC
    Toxins (Basel); 2014 Feb; 6(3):892-913. PubMed ID: 24590385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional role of Kv1.1 and Kv1.3 channels in the neoplastic progression steps of three cancer cell lines, elucidated by scorpion peptides.
    Aissaoui D; Mlayah-Bellalouna S; Jebali J; Abdelkafi-Koubaa Z; Souid S; Moslah W; Othman H; Luis J; ElAyeb M; Marrakchi N; Essafi-Benkhadir K; Srairi-Abid N
    Int J Biol Macromol; 2018 May; 111():1146-1155. PubMed ID: 29415410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels.
    Bartok A; Toth A; Somodi S; Szanto TG; Hajdu P; Panyi G; Varga Z
    Toxicon; 2014 Sep; 87():6-16. PubMed ID: 24878374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemitoxin, the first potassium channel toxin from the venom of the Iranian scorpion Hemiscorpius lepturus.
    Srairi-Abid N; Shahbazzadeh D; Chatti I; Mlayah-Bellalouna S; Mejdoub H; Borchani L; Benkhalifa R; Akbari A; El Ayeb M
    FEBS J; 2008 Sep; 275(18):4641-50. PubMed ID: 18699777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A selective blocker of Kv1.2 and Kv1.3 potassium channels from the venom of the scorpion Centruroides suffusus suffusus.
    Corzo G; Papp F; Varga Z; Barraza O; Espino-Solis PG; Rodríguez de la Vega RC; Gaspar R; Panyi G; Possani LD
    Biochem Pharmacol; 2008 Oct; 76(9):1142-54. PubMed ID: 18786511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new type of scorpion Na+-channel-toxin-like polypeptide active on K+ channels.
    Srairi-Abid N; Guijarro JI; Benkhalifa R; Mantegazza M; Cheikh A; Ben Aissa M; Haumont PY; Delepierre M; El Ayeb M
    Biochem J; 2005 Jun; 388(Pt 2):455-64. PubMed ID: 15656785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.
    Chang SC; Huq R; Chhabra S; Beeton C; Pennington MW; Smith BJ; Norton RS
    FEBS J; 2015 Jun; 282(12):2247-59. PubMed ID: 25864722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A potent potassium channel blocker from Mesobuthus eupeus scorpion venom.
    Gao B; Peigneur S; Tytgat J; Zhu S
    Biochimie; 2010 Dec; 92(12):1847-53. PubMed ID: 20713119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease.
    Han S; Yi H; Yin SJ; Chen ZY; Liu H; Cao ZJ; Wu YL; Li WX
    J Biol Chem; 2008 Jul; 283(27):19058-65. PubMed ID: 18480054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ImKTx1, a new Kv1.3 channel blocker with a unique primary structure.
    Chen Z; Hu Y; Han S; Yin S; He Y; Wu Y; Cao Z; Li W
    J Biochem Mol Toxicol; 2011; 25(4):244-51. PubMed ID: 21308893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Revealing the molecular determinants of neurotoxin specificity for calcium-activated versus voltage-dependent potassium channels.
    Giangiacomo KM; Becker J; Garsky C; Felix JP; Priest BT; Schmalhofer W; Garcia ML; Mullmann TJ
    Biochemistry; 2007 May; 46(18):5358-64. PubMed ID: 17439246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog.
    Tanner MR; Tajhya RB; Huq R; Gehrmann EJ; Rodarte KE; Atik MA; Norton RS; Pennington MW; Beeton C
    Clin Immunol; 2017 Jul; 180():45-57. PubMed ID: 28389388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tst26, a novel peptide blocker of Kv1.2 and Kv1.3 channels from the venom of Tityus stigmurus.
    Papp F; Batista CV; Varga Z; Herceg M; Román-González SA; Gaspar R; Possani LD; Panyi G
    Toxicon; 2009 Sep; 54(4):379-89. PubMed ID: 19500613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel alpha-KTx peptides from the venom of the scorpion Centruroides elegans selectively blockade Kv1.3 over IKCa1 K+ channels of T cells.
    Olamendi-Portugal T; Somodi S; Fernández JA; Zamudio FZ; Becerril B; Varga Z; Panyi G; Gáspár R; Possani LD
    Toxicon; 2005 Sep; 46(4):418-29. PubMed ID: 16026809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, 3-D structure, and pharmacology of a reticulated chimeric peptide derived from maurotoxin and Tsk scorpion toxins.
    Fajloun Z; Ferrat G; Carlier E; M'Barek S; Regaya I; Fathallah M; Rochat H; Darbon H; de Waard M; Sabatier JM
    Biochem Biophys Res Commun; 2002 Mar; 291(3):640-8. PubMed ID: 11855838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maurotoxin and the Kv1.1 channel: voltage-dependent binding upon enantiomerization of the scorpion toxin disulfide bridge Cys31-Cys34.
    Lecomte C; Ben Khalifa R; Martin-Eauclaire MF; Kharrat R; El Ayeb M; Darbon H; Rochat H; Crest M; Sabatier JM
    J Pept Res; 2000 Mar; 55(3):246-54. PubMed ID: 10727107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental conversion of a defensin into a neurotoxin: implications for origin of toxic function.
    Zhu S; Peigneur S; Gao B; Umetsu Y; Ohki S; Tytgat J
    Mol Biol Evol; 2014 Mar; 31(3):546-59. PubMed ID: 24425781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and characterization of Pi4, a scorpion toxin from Pandinus imperator that acts on K+ channels.
    M'Barek S; Mosbah A; Sandoz G; Fajloun Z; Olamendi-Portugal T; Rochat H; Sampieri F; Guijarro JI; Mansuelle P; Delepierre M; De Waard M; Sabatier JM
    Eur J Biochem; 2003 Sep; 270(17):3583-92. PubMed ID: 12919322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-Terminal residues in small potassium channel blockers OdK1 and OSK3 from scorpion venom fine-tune the selectivity.
    Kuzmenkov AI; Peigneur S; Chugunov AO; Tabakmakher VM; Efremov RG; Tytgat J; Grishin EV; Vassilevski AA
    Biochim Biophys Acta Proteins Proteom; 2017 May; 1865(5):465-472. PubMed ID: 28179135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cm28, a scorpion toxin having a unique primary structure, inhibits KV1.2 and KV1.3 with high affinity.
    Naseem MU; Carcamo-Noriega E; Beltrán-Vidal J; Borrego J; Szanto TG; Zamudio FZ; Delgado-Prudencio G; Possani LD; Panyi G
    J Gen Physiol; 2022 Aug; 154(8):. PubMed ID: 35699659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.